| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.08 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.08 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.11 | 0.09 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.09 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.11 | 0.09 |